China Blocks U.S. Pork Imports Due to Banned Animal Drug

Ractopamine is a controversial animal drug that is banned in 160 countries, but not the United States. China is now refusing to allow several pork processing plants in the U.S. to import their meats which they say have tested positive for ractopamine.

The Meat Additive Banned in 160 Countries, But the FDA Claims It’s Safe for Americans

Ractopamine is banned from food production in at least 160 countries around the world, including countries across Europe, Russia, mainland China and Republic of China (Taiwan), due to its suspected health effects. Since 1998, more than 1,700 people have reportedly been “poisoned” from eating pigs fed the drug. If imported meat is found to contain traces of the drug, it is turned away, while fines and imprisonment result for its use in banned countries. While Americans are largely unaware that the drug is even used, many other nations seem to be far better informed. Fear that the ractopamine ban might be lifted brought thousands of demonstrators onto the streets in Taiwan last year, demanding that the ban remain in place. In February of this year, Russia issued a ban on US meat imports, warning it would remain in place until the US agrees to certify that the meat is ractopamine-free. As reported by Pravda, Russia is the fourth largest importer of US meats, purchasing about $500 million-worth of beef and pork annually. At present, the US does not even test for the presence of this drug in meats sold.

Ractopamine: The Meat Additive on Your Plate That’s Banned Almost Everywhere But America

Have you ever heard of ractopamine? Neither have most US food consumers though it is used in 80 percent of US pig and cattle operations. The asthma drug-like growth additive, called a beta-agonist, has enjoyed stealth use in the US food supply for a decade despite being widely banned overseas. Ractopamine is banned in the EU, Russia, China, Taiwan and many other countries. The Center for Food Safety (CFS) and Animal Legal Defense Fund (ALDF) have sued the FDA for withholding records pertaining to ractopamine's safety.